この問題で

GLOBAL PHARMA continues to see potential in investing in R&D IN INDIA

Innovative biopharmaceutical companies around the world continue to strive to accelerate the pace of innovation and deliver effective medicines to patients quickly and
efficiently. By investing more time, energy, and resources in collaboration across the R&D ecosystem and leveraging more sophisticated research and manufacturing
tools, these companies in India continue to invest in R&D and advance the science forward.

Agilent In Agreement With Agendia For Cancer Diagnostics

Agilent Technologies Inc. and Agendia, Inc. have jointly announced an agreement to expand their relationship to include the development of an RNA Seq kit version of Agendia’s currently marketed Mamma Print and Blueprint tests.

1 min

Nanoparticles For Treating Eye Infections

Scientists at the Hyderabad-based CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB) have developed a novel way to treat fungal keratitis.

1 min

Global Pharma Continues To See Potential In Investing In R&D In India

Innovative biopharmaceutical companies around the world continue to strive to accelerate the pace of innovation and deliver effective medicines to patients quickly and efficiently. By investing more time, energy, and resources in collaboration across the R&D ecosystem and leveraging more sophisticated research and manufacturing tools, these companies in India continue to invest in R&D and advance the science forward.

6 mins

We are excited to be a part of this life sciences Industry

We are excited to be a part of this life sciences Industry

5 mins

Competition Is Getting Fierce Among The 'Health Startups' In India

Medical care is just a click away but this has also blown a trumpet of online combat between these startups. Currently, it may look like a wide field to play in but in the coming years, there will be more players joining these online battle and then it will become a cut throat competition

9 mins

GST To Have Constructive Effect On The Pharma And Healthcare Sectors

Though healthcare and pharma sectors hailed the announcement of GST rates, by saying that GST will encourage local manufacturing sector to step into producing products that will be more affordable for the local consumers. But with introduction of GST ayurvedic medicines will be taxed at 12 per cent from the current tax rate of 7 per cent, which has disappointed the Ayurvedic medicines industry badly.

5 mins

There Is Need To Increase Awareness About Clinical Research That Has Done Good For Patients

There Is Need To Increase Awareness About Clinical Research That Has Done Good For Patients

4 mins

Empowered By Innovation

We are setting up Med Tech Accelerator within our existing state of art campus.

4 mins

Invest In It Backbone And Interoperability Standards In Healthcare

Digital technologies can help both private and public sector’s program leaders to improve service delivery for all and the digital health programmes would have much deeper impact for rural masses

4 mins

The New Challenges Demand That We Make Innovative Strategies: J P Nadda

The New Challenges Demand That We Make Innovative Strategies: J P Nadda

2 mins

Bio Spectrum の記事をすべて読む

Bio Spectrum Magazine Description:

India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.